<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - [REDACTED]</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">REASON FOR VISIT</a></li><li><a href="#id3">Medications</a></li><li><a href="#id4">Social History</a></li><li><a href="#id5">Problems</a></li><li><a href="#id6">Vital Signs</a></li><li><a href="#id7">Encounters</a></li><li><a href="#id8">Assessments</a></li><li><a href="#id9">Plan Of Treatment</a></li><li><a href="#id10">Progress Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><span class="content_span">No Known Allergies</span></div><h3><a name="id2" href="#toc">REASON FOR VISIT</a></h3><div>3 month f/u-LABS IN CHART</div><h3><a name="id3" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Atorvastatin Calcium 40 MG Tablet</td><td ID="instruction1">1 tablet Orally Once a day</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication2">metFORMIN HCl 500 MG Tablet</td><td ID="instruction2">1 tablet with a meal Orally Once a day</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication3">amLODIPine Besylate 5 MG Tablet</td><td ID="instruction3">1 tablet Orally Once a day; Duration: 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication4">Tamsulosin HCl 0.4 MG Capsule</td><td ID="instruction4">TAKE 1 CAPSULE BY MOUTH DAILY; Duration: 90</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication5">Lisinopril 20 MG Tablet</td><td ID="instruction5">1 tablet Orally Once a day; Duration: 90 days</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Social History</a></h3><div><span class="content_span">Tobacco Use:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th><th>Date</th></tr></thead><tbody><tr><td ID="smokingStatus1">Details (start date - stop date)</td><td>Never Smoker</td><td>NA - NA</td></tr></tbody></table><span class="content_span">Sex Assigned At Birth:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th></tr></thead><tbody><tr><td ID="BirthSexInfo">Sex Assigned At Birth</td><td>Male</td></tr></tbody></table><span class="content_span">Social History</span><table ID="socialhistorynotes" width="100%" border="1"><tbody><tr><td colspan="4"/></tr><tr><th colspan="4">Drugs/Alcohol:</th></tr><tr><th>Social Info</th><th>Question</th><th>Answer</th><th>Notes</th></tr><tr><td>Drugs</td><td>Have you used drugs other than those for medical reasons in the past 12 months?</td><td>No</td><td/></tr><tr><td>Caffeine</td><td>Intake:</td><td>1-2 cups per day</td><td/></tr></tbody><tbody><tr><td colspan="4"/></tr><tr><th colspan="4">Drug/Alcohol (SmartForms):</th></tr><tr><th>Social Info</th><th>Question</th><th>Answer</th><th>Notes</th></tr><tr><td rowspan="3">AUDIT-C (Standard)</td><td>Did you have a drink containing alcohol in the past year?</td><td>No</td><td/></tr><tr><td>Points</td><td>0</td><td/></tr><tr><td>Interpretation</td><td>Negative</td><td/></tr></tbody><tbody><tr><td colspan="4"/></tr><tr><th colspan="4">Tobacco Use:</th></tr><tr><th>Social Info</th><th>Question</th><th>Answer</th><th>Notes</th></tr><tr><td>Tobacco Use/Smoking</td><td>Tobacco use:</td><td>nonsmoker</td><td/></tr></tbody></table></div><h3><a name="id5" href="#toc">Problems</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>SNOMED Code</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td/><td ID="Problem1">BMI 32-32.9 (Z68.32)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr></tbody></table></div><h3><a name="id6" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Temperature</th><td>98.4 degrees Fahrenheit</td><td>[REDACTED]</td></tr><tr><th ID="vital2">Blood pressure systolic</th><td>128 mm Hg</td><td>[REDACTED]</td></tr><tr><th ID="vital3">Blood pressure diastolic</th><td>74 mm Hg</td><td>[REDACTED]</td></tr><tr><th ID="vital4">Heart Rate</th><td>70 /min</td><td>[REDACTED]</td></tr><tr><th ID="vital5">Respiratory Rate</th><td>16 /min</td><td>[REDACTED]</td></tr><tr><th ID="vital6">Height</th><td>65 in</td><td>[REDACTED]</td></tr><tr><th ID="vital7">Weight</th><td>198 lbs</td><td>[REDACTED]</td></tr><tr><th ID="vital8">BMI</th><td>32.95 kg/m2</td><td>[REDACTED]</td></tr><tr><th ID="vital9">Oximetry</th><td>96 %</td><td>[REDACTED]</td></tr><tr><th ID="vital10">Height-cm</th><td>165.1 cm</td><td>[REDACTED]</td></tr><tr><th ID="vital11">Weight-kg</th><td>89.81 kg</td><td>[REDACTED]</td></tr></tbody></table></div><h3><a name="id7" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>MCM Port [REDACTED]</td><td>[REDACTED][REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Chronic diastolic (congestive) heart failure I50.32 ; Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I13.0 ; Chronic kidney disease, stage 2 (mild) N18.2 ; Type 2 diabetes mellitus with diabetic chronic kidney disease E11.22 ; Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin E11.69 ; Mixed hyperlipidemia E78.2 and BMI 32-32.9 Z68.32</td></tr></tbody></table></div><h3><a name="id8" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th><th>Section Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>Chronic diastolic (congestive) heart failure (ICD-10 - I50.32)</td><td/><td><p>[REDACTED]_ECHOCARDIOGRAM: Normal left ventricular chamber</p><p>size with mild concentric hypertrophy and normal wall motion ejection fraction</p><p>55 to 60%. Mild sclerosis of the aortic root. Mild mitral insufficiency.</p><p>Impaired left ventricular relaxation with mildly elevated left ventricular</p><p>filling pressures</p><p> Asymptomatic Controlled with current medications. </p></td><td/><td/></tr><tr><td ID="ref2">[REDACTED]</td><td>Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (ICD-10 - I13.0)</td><td/><td><p>Patient was recommended to follow his/her low salt diet.  Patient was recommended to take medications as directed and be compliant.  Patient is recommended to exercise.  Patient is to check blood pressure at home and call us if it's over 130/80 or less than 100/60 and the heart rate being over 100 or less than 50. - Will keep monitoring GFR </p><p>- DIET: Decrease the daily intake of sodium, phosphorus, calcium and potassium - avoid NSAID, dehydration, contrast material.</p></td><td/><td/></tr><tr><td ID="ref3">[REDACTED]</td><td>Chronic kidney disease, stage 2 (mild) (ICD-10 - N18.2)</td><td/><td><p>- Will keep monitoring GFR </p><p>- DIET: Decrease the daily intake of sodium, phosphorus, calcium and potassium - avoid NSAID, dehydration, contrast material.</p></td><td/><td/></tr><tr><td ID="ref4">[REDACTED]</td><td>Type 2 diabetes mellitus with diabetic chronic kidney disease (ICD-10 - E11.22)</td><td/><td>cont medications as directed</td><td/><td/></tr><tr><td ID="ref5">[REDACTED]</td><td>Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin (ICD-10 - E11.69)</td><td/><td><p>Pt was taking metformin 500mg daily recommended to come back to take 1000mg daily. </p><p>This is associated with hyperlipidemia. Continue with a low glycemic diet. Discussed the importance of taking a statin. LDL goal &lt;100 and A1c goal &lt;8%. Follow up with PCP.</p></td><td/><td/></tr><tr><td ID="ref6">[REDACTED]</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td/><td>Follow low fat diet, increase physical activity, and medication compliance a must, make sure to keep routine lab updates to evaluate cholesterol.</td><td/><td/></tr><tr><td ID="ref7">[REDACTED]</td><td>BMI 32-32.9 (ICD-10 - Z68.32)</td><td/><td/><td/><td/></tr><tr><td ID="ref8">[REDACTED]</td><td>Other</td><td/><td><p>  Walk 30 minutes 5 days each week.</p><p>Verbalize an understanding of the relationship between weight loss, weight control, and exercise.</p></td><td/><td/></tr></tbody></table></div><h3><a name="id9" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Medication</span><table width="100%" border="1"><thead><tr><th>Medication Name</th><th>Sig</th><th>Start Date</th><th>Stop Date</th><th>Notes</th></tr></thead><tbody><tr><td ID="potMeds1">Atorvastatin Calcium 40 MG Tablet</td><td>1 tablet Orally Once a day</td><td>[REDACTED]</td><td/><td/></tr><tr><td ID="potMeds2">metFORMIN HCl 500 MG Tablet</td><td>1 tablet with a meal Orally Once a day</td><td>[REDACTED]</td><td/><td/></tr></tbody></table><span class="content_span">Treatment Notes</span><table width="100%" border="1"><thead><tr><th>Assessment</th><th>Notes</th></tr></thead><tbody><tr><td ID="instructionpot1">Chronic diastolic (congestive) heart failure</td><td><p>[REDACTED]_ECHOCARDIOGRAM: Normal left ventricular chamber</p><p>size with mild concentric hypertrophy and normal wall motion ejection fraction</p><p>55 to 60%. Mild sclerosis of the aortic root. Mild mitral insufficiency.</p><p>Impaired left ventricular relaxation with mildly elevated left ventricular</p><p>filling pressures</p><p> Asymptomatic Controlled with current medications. </p></td></tr><tr><td ID="instructionpot2">Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</td><td><p>Patient was recommended to follow his/her low salt diet.  Patient was recommended to take medications as directed and be compliant.  Patient is recommended to exercise.  Patient is to check blood pressure at home and call us if it's over 130/80 or less than 100/60 and the heart rate being over 100 or less than 50. - Will keep monitoring GFR </p><p>- DIET: Decrease the daily intake of sodium, phosphorus, calcium and potassium - avoid NSAID, dehydration, contrast material.</p></td></tr><tr><td ID="instructionpot3">Chronic kidney disease, stage 2 (mild)</td><td><p>- Will keep monitoring GFR </p><p>- DIET: Decrease the daily intake of sodium, phosphorus, calcium and potassium - avoid NSAID, dehydration, contrast material.</p></td></tr><tr><td ID="instructionpot4">Type 2 diabetes mellitus with diabetic chronic kidney disease</td><td>cont medications as directed</td></tr><tr><td ID="instructionpot5">Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin</td><td><p>Pt was taking metformin 500mg daily recommended to come back to take 1000mg daily. </p><p>This is associated with hyperlipidemia. Continue with a low glycemic diet. Discussed the importance of taking a statin. LDL goal &lt;100 and A1c goal &lt;8%. Follow up with PCP.</p></td></tr><tr><td ID="instructionpot6">Mixed hyperlipidemia</td><td>Follow low fat diet, increase physical activity, and medication compliance a must, make sure to keep routine lab updates to evaluate cholesterol.</td></tr><tr><td ID="instructionpot7">Other</td><td><p>  Walk 30 minutes 5 days each week.</p><p>Verbalize an understanding of the relationship between weight loss, weight control, and exercise.</p></td></tr></tbody></table><span class="content_span">Future Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="futureTest1">Hemoglobin A1c-001453</td><td>[REDACTED]</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: 3 Months, Reason: Labs 1 week before office visit</td></tr><tr><td ID="futureAppt1">Provider Name:[REDACTED], [REDACTED] 08:40:00 AM, [REDACTED][REDACTED][REDACTED][REDACTED], [REDACTED]</td></tr></tbody></table></div><h3><a name="id10" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>[REDACTED] [REDACTED] <span class="bold">DOB:</span> [REDACTED] ([REDACTED] M) <span class="bold">Acc No.</span> 811463 <span class="bold">DOS:</span> [REDACTED]</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold"/></td></tr><tr><td align="left"><span class="bold">Patient: </span>[REDACTED] [REDACTED]<br/><span class="bold">Account Number: </span>811463</td><td align="right"><span class="bold">Provider: </span>[REDACTED], ARNP</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>[REDACTED]<span class="bold">   Age: </span>80 Y<span class="bold">   Sex: </span>Male</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td><span class="bold">Phone: </span>[REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Address: </span>[REDACTED][REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Pcp: </span>[REDACTED]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   3 month f/u-LABS IN CHART </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">[REDACTED]</span>: <br/>       Patient here [REDACTED] for his f/u visit and meds refill, has no new c/o reported Patient does not complain of any , shortness of breath or chest pain Patients current medication were reviewed and Refills given as in chart. , Ptn does not report any side effects of any meds <br/>follow up on Type 2 diabetes mellitus On metformin  	<br/>follow up on Mixed hyperlipidemia On statins  	<br/>follow up on hypertension On amlodipine and lisinopril, <br/>follow up on BENIGN NODULAR PROSTATIC HYPERPLASIA  On tamsulosin<br/>Labs Reviewed [REDACTED] GFR 87, A1C 7.4 (7.3).</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">ROS:</span> <br/>   <span class="Underline">General / Constitutional</span>: <br/>      Change in appetite denies. Chills denies. Fatigue denies.   <br/>   <span class="Underline">Ophthalmologic</span>: <br/>      Blurry vision denies. Discharge denies. Itching and redness of the eye(s) denies.   <br/>   <span class="Underline">ENT</span>: <br/>      Runny nose denies. Decreased hearing denies. Nosebleed denies. Ringing in the ears denies. Sinus pain denies. Sore throat denies. Swollen glands denies.   <br/>   <span class="Underline">Endocrine</span>: <br/>      Cold intolerance denies. Excessive thirst denies. Weight loss denies. Weight gain denies.   <br/>   <span class="Underline">Respiratory</span>: <br/>      Cough denies. Hemoptysis denies. Pain with inspiration denies. Shortness of breath with exertion denies. Sputum production denies. Wheezing denies.   <br/>   <span class="Underline">Cardiovascular</span>: <br/>      Chest pain denies. Difficulty laying flat denies. Orthopnea denies. Palpitations denies.   <br/>   <span class="Underline">Gastrointestinal</span>: <br/>      Abdominal pain denies. Change in bowel habits denies. Constipation denies. Diarrhea denies. Difficulty swallowing denies. Heartburn denies. Nausea denies<br/>. Vomiting denies.   <br/>   <span class="Underline">Hematology</span>: <br/>      Bleeding disorder denies.   <br/>   <span class="Underline">Genitourinary</span>: <br/>      Blood in the urine denies. Difficulty urinating denies. Frequent urination denies. Painful urination denies.   <br/>   <span class="Underline">Musculoskeletal</span>: <br/>      Knee pain denies. Back pain denies. Joint stiffness denies. Muscle aches denies. Pain in shoulder(s) denies. Swollen joints denies.   <br/>   <span class="Underline">Peripheral Vascular</span>: <br/>      Cold extremities denies. Pain / cramping in legs after exertion denies. Painful extremities denies. Ulceration of feet denies. Varicose veins denies.   <br/>   <span class="Underline">Podiatric</span>: <br/>      Ankle pain denies. Ball of foot pain denies. Foot pain denies. Sole pain denies.   <br/>   <span class="Underline">Skin</span>: <br/>      Dry skin denies. Eczema denies. Hair changes denies. Itching denies. Mole(s) denies. Rash denies.   <br/>   <span class="Underline">Neurologic</span>: <br/>      Dizziness denies. Fainting denies. Gait abnormality denies. Headache denies. Memory loss denies. Seizures denies. Tingling / numbness denies. Tremor denies. Lightheadedness denies.   <br/>   <span class="Underline">Psychiatric</span>: <br/>      Anxiety denies. Auditory / visual hallucinations denies. Delusions denies. Depressed mood denies. Difficulty sleeping denies. Loss of appetite denies. Stressors denies. Suicidal thoughts denies. Homicidal thoughts denies.   <br/>   </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> <br/>Diabetes<br/>Hyperlipidemia<br/>Medical History Verified</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Surgical History:</span> <br/>cholecystectomy 2020 <br/>Surgical History verified. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Hospitalization/Major Diagnostic Procedure:</span> <br/>Denies Past Hospitalization. <br/>Hospitalization Verified. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Family History:</span> Father: unknown. Mother: unknown. 3 brother(s) , 3 sister(s)  - healthy. 1 son(s) , 2 daughter(s)  - healthy. . <br/>brother- 1998 died of massive heartaattack<br/>brother- alcoholic cirrosis.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Social History:</span> <br/>   <span class="Underline">Tobacco Use:</span> Tobacco Use/Smoking Tobacco use: nonsmoker. <br/>   <span class="Underline">Drugs/Alcohol:</span> Drugs Have you used drugs other than those for medical reasons in the past 12 months? No. Caffeine Intake: 1-2 cups per day. <br/>   <span class="Underline">Drug/Alcohol (SmartForms):</span> AUDIT-C (Standard) Did you have a drink containing alcohol in the past year? No, Points 0, Interpretation Negative. <br/></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> TakingLisinopril 20 MG Tablet 1 tablet Orally Once a day Atorvastatin Calcium 40 MG Tablet 1 tablet Orally Once a day metFORMIN HCl 1000 MG Tablet 1 tablet with a meal Orally Once a day amLODIPine Besylate 5 MG Tablet 1 tablet Orally Once a day Tamsulosin HCl 0.4 MG Capsule TAKE 1 CAPSULE BY MOUTH DAILY   Taking Lisinopril 20 MG Tablet 1 tablet Orally Once a day Taking Atorvastatin Calcium 40 MG Tablet 1 tablet Orally Once a day Taking metFORMIN HCl 1000 MG Tablet 1 tablet with a meal Orally Once a day Taking amLODIPine Besylate 5 MG Tablet 1 tablet Orally Once a day Taking Tamsulosin HCl 0.4 MG Capsule TAKE 1 CAPSULE BY MOUTH DAILY   </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span> N.K.D.A.yesAllergies Verified.</td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> Ht: 65 in, Wt: <span class="bold">198</span> lbs, Wt-kg: 89.81 kg, BMI: <span class="bold">32.95</span> Index, BP: <span class="bold">128/74</span> mm Hg, HR: <span class="bold">70</span> /min, Temp: <span class="bold">98.4</span> F, RR: <span class="bold">16</span> /min, Oxygen sat %: <span class="bold">96</span> %, Pain scale: <span class="bold">0</span> 1-10, Body Surface Area: 2.03, Ht-cm: 165.1 cm.</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td><span class="bold">   Past Orders:</span></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:TSH reflex to T4-322454</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Collection Time</td><td align="left">07:37 AM</td><td align="left"/></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">TSH</td><td align="left">3.120<br/>(Ref Range: 0.450-4.500 uIU/mL)</td><td align="left">TNP<br/>(Ref Range: uIU/mL)</td></tr><tr><td align="left">Request Problem</td><td align="left">NR<br/></td><td align="left">TNP<br/></td></tr><tr><td align="left">Notes:</td><td align="left">[REDACTED] [REDACTED] 04:25:07 PM EDT &gt;GFR 87, A1C 7.4 (7.3),</td><td align="left">[REDACTED] [REDACTED] 09:04:50 AM EST &gt;6.3 H, normal lipid panel,</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:Hemoglobin A1c-001453</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Collection Time</td><td align="left">07:37 AM</td><td align="left">08:49 AM</td><td align="left">08:22 AM</td><td align="left"/><td align="left"/></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Hemoglobin A1c</td><td class="bold" align="left">7.4    H<br/>(Ref Range: 4.8-5.6 %)</td><td class="bold" align="left">7.3    H<br/>(Ref Range: 4.8-5.6 %)</td><td class="bold" align="left">7.2    H<br/>(Ref Range: 4.8-5.6 %)</td><td class="bold" align="left">7.4    H<br/>(Ref Range: 4.8-5.6 %)</td><td class="bold" align="left">6.3    H<br/>(Ref Range: 4.8-5.6 %)</td></tr><tr><td align="left">Notes:</td><td align="left">[REDACTED] [REDACTED] 04:25:07 PM EDT &gt;GFR 87, A1C 7.4 (7.3),</td><td align="left">[REDACTED] [REDACTED] 08:30:45 AM EST &gt;a1c 7.3, gfr 87,</td><td align="left">[REDACTED] [REDACTED] 02:22:54 PM EST &gt;Ab /creat ratio 45H, GFR 84, A1C 7.2 (7.4), TG 153 (191),</td><td align="left">[REDACTED] [REDACTED] 09:35:52 AM EDT &gt;a1c 7.4,</td><td align="left">[REDACTED] [REDACTED] 09:04:50 AM EST &gt;6.3 H, normal lipid panel,</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:Lipid Panel-303756</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Collection Time</td><td align="left">07:37 AM</td><td align="left">08:49 AM</td><td align="left">08:22 AM</td><td align="left"/><td align="left"/></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Cholesterol, Total</td><td align="left">112<br/>(Ref Range: 100-199 mg/dL)</td><td align="left">106<br/>(Ref Range: 100-199 mg/dL)</td><td align="left">128<br/>(Ref Range: 100-199 mg/dL)</td><td align="left">110<br/>(Ref Range: 100-199 mg/dL)</td><td align="left">TNP<br/>(Ref Range: mg/dL)</td></tr><tr><td align="left">Triglycerides</td><td align="left">147<br/>(Ref Range: 0-149 mg/dL)</td><td align="left">128<br/>(Ref Range: 0-149 mg/dL)</td><td class="bold" align="left">153    H<br/>(Ref Range: 0-149 mg/dL)</td><td class="bold" align="left">191    H<br/>(Ref Range: 0-149 mg/dL)</td><td align="left">TNP<br/></td></tr><tr><td align="left">HDL Cholesterol</td><td class="bold" align="left">31    L<br/>(Ref Range: &gt;39 mg/dL)</td><td class="bold" align="left">36    L<br/>(Ref Range: &gt;39 mg/dL)</td><td class="bold" align="left">39    L<br/>(Ref Range: &gt;39 mg/dL)</td><td class="bold" align="left">32    L<br/>(Ref Range: &gt;39 mg/dL)</td><td align="left">TNP<br/></td></tr><tr><td align="left">VLDL Cholesterol Cal</td><td align="left">26<br/>(Ref Range: 5-40 mg/dL)</td><td align="left">23<br/>(Ref Range: 5-40 mg/dL)</td><td align="left">26<br/>(Ref Range: 5-40 mg/dL)</td><td align="left">31<br/>(Ref Range: 5-40 mg/dL)</td><td align="left">TNP<br/>(Ref Range: mg/dL)</td></tr><tr><td align="left">LDL Chol Calc (NIH)</td><td align="left">55<br/>(Ref Range: 0-99 mg/dL)</td><td align="left">47<br/>(Ref Range: 0-99 mg/dL)</td><td align="left">63<br/>(Ref Range: 0-99 mg/dL)</td><td align="left">47<br/>(Ref Range: 0-99 mg/dL)</td><td align="left">NR<br/></td></tr><tr><td align="left">Notes:</td><td align="left">[REDACTED] [REDACTED] 04:25:07 PM EDT &gt;GFR 87, A1C 7.4 (7.3),</td><td align="left">[REDACTED] [REDACTED] 08:30:45 AM EST &gt;a1c 7.3, gfr 87,</td><td align="left">[REDACTED] [REDACTED] 02:22:54 PM EST &gt;Ab /creat ratio 45H, GFR 84, A1C 7.2 (7.4), TG 153 (191),</td><td align="left">[REDACTED] [REDACTED] 04:46:55 PM EST &gt;Tg 191H, GFR 92, PSA 2.6</td><td align="left">[REDACTED] [REDACTED] 09:04:50 AM EST &gt;6.3 H, normal lipid panel,</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:CMP14+eGFR-334943</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Collection Time</td><td align="left">07:37 AM</td><td align="left">08:49 AM</td><td align="left">08:22 AM</td><td align="left"/></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Glucose</td><td class="bold" align="left">147    H<br/>(Ref Range: 70-99 mg/dL)</td><td class="bold" align="left">123    H<br/>(Ref Range: 70-99 mg/dL)</td><td class="bold" align="left">129    H<br/>(Ref Range: 70-99 mg/dL)</td><td align="left">TNP<br/>(Ref Range: mg/dL)</td></tr><tr><td align="left">BUN</td><td align="left">10<br/>(Ref Range: 8-27 mg/dL)</td><td align="left">13<br/>(Ref Range: 8-27 mg/dL)</td><td align="left">14<br/>(Ref Range: 8-27 mg/dL)</td><td align="left">TNP<br/></td></tr><tr><td align="left">Creatinine</td><td align="left">0.88<br/>(Ref Range: 0.76-1.27 mg/dL)</td><td align="left">0.87<br/>(Ref Range: 0.76-1.27 mg/dL)</td><td align="left">0.92<br/>(Ref Range: 0.76-1.27 mg/dL)</td><td align="left">TNP<br/></td></tr><tr><td align="left">eGFR</td><td align="left">87<br/>(Ref Range: &gt;59 mL/min/1.73)</td><td align="left">87<br/>(Ref Range: &gt;59 mL/min/1.73)</td><td align="left">84<br/>(Ref Range: &gt;59 mL/min/1.73)</td><td align="left">NR<br/></td></tr><tr><td align="left">BUN/Creatinine Ratio</td><td align="left">11<br/>(Ref Range: 10-24)</td><td align="left">15<br/>(Ref Range: 10-24)</td><td align="left">15<br/>(Ref Range: 10-24)</td><td align="left">NR<br/></td></tr><tr><td align="left">Sodium</td><td align="left">143<br/>(Ref Range: 134-144 mmol/L)</td><td align="left">142<br/>(Ref Range: 134-144 mmol/L)</td><td align="left">144<br/>(Ref Range: 134-144 mmol/L)</td><td align="left">TNP<br/></td></tr><tr><td align="left">Potassium</td><td align="left">4.5<br/>(Ref Range: 3.5-5.2 mmol/L)</td><td align="left">5.2<br/>(Ref Range: 3.5-5.2 mmol/L)</td><td align="left">4.6<br/>(Ref Range: 3.5-5.2 mmol/L)</td><td align="left">TNP<br/></td></tr><tr><td align="left">Chloride</td><td align="left">105<br/>(Ref Range: 96-106 mmol/L)</td><td align="left">106<br/>(Ref Range: 96-106 mmol/L)</td><td align="left">104<br/>(Ref Range: 96-106 mmol/L)</td><td align="left">TNP<br/></td></tr><tr><td align="left">Carbon Dioxide, Total</td><td align="left">21<br/>(Ref Range: 20-29 mmol/L)</td><td align="left">23<br/>(Ref Range: 20-29 mmol/L)</td><td align="left">21<br/>(Ref Range: 20-29 mmol/L)</td><td align="left">TNP<br/></td></tr><tr><td align="left">Calcium</td><td align="left">9.3<br/>(Ref Range: 8.6-10.2 mg/dL)</td><td align="left">9.4<br/>(Ref Range: 8.6-10.2 mg/dL)</td><td align="left">9.5<br/>(Ref Range: 8.6-10.2 mg/dL)</td><td align="left">TNP<br/></td></tr><tr><td align="left">Protein, Total</td><td align="left">6.6<br/>(Ref Range: 6.0-8.5 g/dL)</td><td align="left">6.5<br/>(Ref Range: 6.0-8.5 g/dL)</td><td align="left">7.1<br/>(Ref Range: 6.0-8.5 g/dL)</td><td align="left">TNP<br/></td></tr><tr><td align="left">Albumin</td><td align="left">4.2<br/>(Ref Range: 3.8-4.8 g/dL)</td><td align="left">4.3<br/>(Ref Range: 3.8-4.8 g/dL)</td><td align="left">4.4<br/>(Ref Range: 3.8-4.8 g/dL)</td><td align="left">TNP<br/></td></tr><tr><td align="left">Globulin, Total</td><td align="left">2.4<br/>(Ref Range: 1.5-4.5 g/dL)</td><td align="left">2.2<br/>(Ref Range: 1.5-4.5 g/dL)</td><td align="left">2.7<br/>(Ref Range: 1.5-4.5 g/dL)</td><td align="left">NR<br/></td></tr><tr><td align="left">Bilirubin, Total</td><td align="left">0.5<br/>(Ref Range: 0.0-1.2 mg/dL)</td><td align="left">0.4<br/>(Ref Range: 0.0-1.2 mg/dL)</td><td align="left">0.5<br/>(Ref Range: 0.0-1.2 mg/dL)</td><td align="left">TNP<br/></td></tr><tr><td align="left">Alkaline Phosphatase</td><td align="left">90<br/>(Ref Range: 44-121 IU/L)</td><td align="left">73<br/>(Ref Range: 44-121 IU/L)</td><td align="left">82<br/>(Ref Range: 44-121 IU/L)</td><td align="left">TNP<br/></td></tr><tr><td align="left">AST (SGOT)</td><td align="left">22<br/>(Ref Range: 0-40 IU/L)</td><td align="left">22<br/>(Ref Range: 0-40 IU/L)</td><td align="left">22<br/>(Ref Range: 0-40 IU/L)</td><td align="left">TNP<br/></td></tr><tr><td align="left">ALT (SGPT)</td><td align="left">28<br/>(Ref Range: 0-44 IU/L)</td><td align="left">22<br/>(Ref Range: 0-44 IU/L)</td><td align="left">23<br/>(Ref Range: 0-44 IU/L)</td><td align="left">TNP<br/></td></tr><tr><td align="left">Notes:</td><td align="left">[REDACTED] [REDACTED] 04:25:07 PM EDT &gt;GFR 87, A1C 7.4 (7.3),</td><td align="left">[REDACTED] [REDACTED] 08:30:45 AM EST &gt;a1c 7.3, gfr 87,</td><td align="left">[REDACTED] [REDACTED] 02:22:54 PM EST &gt;Ab /creat ratio 45H, GFR 84, A1C 7.2 (7.4), TG 153 (191),</td><td align="left">[REDACTED] [REDACTED] 09:04:50 AM EST &gt;6.3 H, normal lipid panel,</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:CBC With Differential/Platelet-005009</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Collection Time</td><td align="left">07:37 AM</td><td align="left">08:22 AM</td><td align="left"/></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">WBC</td><td align="left">7.6<br/>(Ref Range: 3.4-10.8 x10E3/uL)</td><td align="left">7.2<br/>(Ref Range: 3.4-10.8 x10E3/uL)</td><td align="left">7.0<br/>(Ref Range: 3.4-10.8 x10E3/uL)</td></tr><tr><td align="left">RBC</td><td align="left">4.63<br/>(Ref Range: 4.14-5.80 x10E6/uL)</td><td align="left">4.89<br/>(Ref Range: 4.14-5.80 x10E6/uL)</td><td align="left">4.89<br/>(Ref Range: 4.14-5.80 x10E6/uL)</td></tr><tr><td align="left">Hemoglobin</td><td align="left">13.7<br/>(Ref Range: 13.0-17.7 g/dL)</td><td align="left">14.5<br/>(Ref Range: 13.0-17.7 g/dL)</td><td align="left">14.2<br/>(Ref Range: 13.0-17.7 g/dL)</td></tr><tr><td align="left">Hematocrit</td><td align="left">43.0<br/>(Ref Range: 37.5-51.0 %)</td><td align="left">45.7<br/>(Ref Range: 37.5-51.0 %)</td><td align="left">43.4<br/>(Ref Range: 37.5-51.0 %)</td></tr><tr><td align="left">MCV</td><td align="left">93<br/>(Ref Range: 79-97 fL)</td><td align="left">94<br/>(Ref Range: 79-97 fL)</td><td align="left">89<br/>(Ref Range: 79-97 fL)</td></tr><tr><td align="left">MCH</td><td align="left">29.6<br/>(Ref Range: 26.6-33.0 pg)</td><td align="left">29.7<br/>(Ref Range: 26.6-33.0 pg)</td><td align="left">29.0<br/>(Ref Range: 26.6-33.0 pg)</td></tr><tr><td align="left">MCHC</td><td align="left">31.9<br/>(Ref Range: 31.5-35.7 g/dL)</td><td align="left">31.7<br/>(Ref Range: 31.5-35.7 g/dL)</td><td align="left">32.7<br/>(Ref Range: 31.5-35.7 g/dL)</td></tr><tr><td align="left">RDW</td><td align="left">14.0<br/>(Ref Range: 11.6-15.4 %)</td><td align="left">13.8<br/>(Ref Range: 11.6-15.4 %)</td><td class="bold" align="left">15.7    H<br/>(Ref Range: 11.6-15.4 %)</td></tr><tr><td align="left">Platelets</td><td align="left">210<br/>(Ref Range: 150-450 x10E3/uL)</td><td align="left">209<br/>(Ref Range: 150-450 x10E3/uL)</td><td align="left">194<br/>(Ref Range: 150-450 x10E3/uL)</td></tr><tr><td align="left">Neutrophils</td><td align="left">71<br/>(Ref Range: Not Estab. %)</td><td align="left">70<br/>(Ref Range: Not Estab. %)</td><td align="left">67<br/>(Ref Range: Not Estab. %)</td></tr><tr><td align="left">Lymphs</td><td align="left">16<br/>(Ref Range: Not Estab. %)</td><td align="left">17<br/>(Ref Range: Not Estab. %)</td><td align="left">20<br/>(Ref Range: Not Estab. %)</td></tr><tr><td align="left">Monocytes</td><td align="left">10<br/>(Ref Range: Not Estab. %)</td><td align="left">10<br/>(Ref Range: Not Estab. %)</td><td align="left">9<br/>(Ref Range: Not Estab. %)</td></tr><tr><td align="left">Eos</td><td align="left">2<br/>(Ref Range: Not Estab. %)</td><td align="left">2<br/>(Ref Range: Not Estab. %)</td><td align="left">3<br/>(Ref Range: Not Estab. %)</td></tr><tr><td align="left">Basos</td><td align="left">1<br/>(Ref Range: Not Estab. %)</td><td align="left">1<br/>(Ref Range: Not Estab. %)</td><td align="left">1<br/>(Ref Range: Not Estab. %)</td></tr><tr><td align="left">Neutrophils (Absolute)</td><td align="left">5.4<br/>(Ref Range: 1.4-7.0 x10E3/uL)</td><td align="left">5.0<br/>(Ref Range: 1.4-7.0 x10E3/uL)</td><td align="left">4.8<br/>(Ref Range: 1.4-7.0 x10E3/uL)</td></tr><tr><td align="left">Lymphs (Absolute)</td><td align="left">1.2<br/>(Ref Range: 0.7-3.1 x10E3/uL)</td><td align="left">1.2<br/>(Ref Range: 0.7-3.1 x10E3/uL)</td><td align="left">1.4<br/>(Ref Range: 0.7-3.1 x10E3/uL)</td></tr><tr><td align="left">Monocytes(Absolute)</td><td align="left">0.7<br/>(Ref Range: 0.1-0.9 x10E3/uL)</td><td align="left">0.7<br/>(Ref Range: 0.1-0.9 x10E3/uL)</td><td align="left">0.6<br/>(Ref Range: 0.1-0.9 x10E3/uL)</td></tr><tr><td align="left">Eos (Absolute)</td><td align="left">0.2<br/>(Ref Range: 0.0-0.4 x10E3/uL)</td><td align="left">0.1<br/>(Ref Range: 0.0-0.4 x10E3/uL)</td><td align="left">0.2<br/>(Ref Range: 0.0-0.4 x10E3/uL)</td></tr><tr><td align="left">Baso (Absolute)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.2 x10E3/uL)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.2 x10E3/uL)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.2 x10E3/uL)</td></tr><tr><td align="left">Immature Granulocytes</td><td align="left">0<br/>(Ref Range: Not Estab. %)</td><td align="left">0<br/>(Ref Range: Not Estab. %)</td><td align="left">0<br/>(Ref Range: Not Estab. %)</td></tr><tr><td align="left">Immature Grans (Abs)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.1 x10E3/uL)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.1 x10E3/uL)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.1 x10E3/uL)</td></tr><tr><td align="left">Notes:</td><td align="left">[REDACTED] [REDACTED] 04:25:07 PM EDT &gt;GFR 87, A1C 7.4 (7.3),</td><td align="left">[REDACTED] [REDACTED] 02:22:54 PM EST &gt;Ab /creat ratio 45H, GFR 84, A1C 7.2 (7.4), TG 153 (191),</td><td align="left">[REDACTED] [REDACTED] 09:04:50 AM EST &gt;6.3 H, normal lipid panel,</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><br/><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease - I13.0 (Primary)   <content><span class="bold">Specify : </span>Echo [REDACTED] on Helow records [REDACTED]</content>   2. Chronic diastolic (congestive) heart failure - I50.32   <content><span class="bold">Specify : </span>Echo [REDACTED] on Helow records [REDACTED]</content>   3. Chronic kidney disease, stage 2 (mild) - N18.2   4. Type 2 diabetes mellitus with diabetic chronic kidney disease - E11.22   5. Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin - E11.69   <content><span class="bold">Specify : </span>with associated hyperlipidemia</content>   6. Mixed hyperlipidemia - E78.2   7. BMI 32-32.9 - Z68.32   </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</span> <br/>Notes: Patient was recommended to follow his/her low salt diet. Patient was recommended to take medications as directed and be compliant. Patient is recommended to exercise. Patient is to check blood pressure at home and call us if it's over 130/80 or less than 100/60 and the heart rate being over 100 or less than 50. - Will keep monitoring GFR<br/>- DIET: Decrease the daily intake of sodium, phosphorus, calcium and potassium - avoid NSAID, dehydration, contrast material.  </td></tr><tr><td/></tr><tr><td><span class="bold">2. Chronic diastolic (congestive) heart failure</span> <br/>Notes: [REDACTED]_ECHOCARDIOGRAM: Normal left ventricular chamber size with mild concentric hypertrophy and normal wall motion ejection fraction 55 to 60%. Mild sclerosis of the aortic root. Mild mitral insufficiency. Impaired left ventricular relaxation with mildly elevated left ventricular filling pressures<br/> Asymptomatic Controlled with current medications.   </td></tr><tr><td/></tr><tr><td><span class="bold">3. Chronic kidney disease, stage 2 (mild)</span> <br/>Notes: - Will keep monitoring GFR<br/>- DIET: Decrease the daily intake of sodium, phosphorus, calcium and potassium - avoid NSAID, dehydration, contrast material.  </td></tr><tr><td/></tr><tr><td><span class="bold">4. Type 2 diabetes mellitus with diabetic chronic kidney disease</span> <br/>Notes: cont medications as directed  </td></tr><tr><td/></tr><tr><td><span class="bold">5. Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin</span> <br/>Continue metFORMIN HCl Tablet, 500 MG, 1 tablet with a meal, Orally, Once a day.  <br/>     <span class="Underline">LAB: Hemoglobin A1c-001453 (Ordered for [REDACTED])</span><br/>Notes: Pt was taking metformin 500mg daily recommended to come back to take 1000mg daily. <br/>This is associated with hyperlipidemia. Continue with a low glycemic diet. Discussed the importance of taking a statin. LDL goal &lt;100 and A1c goal &lt;8%. Follow up with PCP.  </td></tr><tr><td/></tr><tr><td><span class="bold">6. Mixed hyperlipidemia</span> <br/>Continue Atorvastatin Calcium Tablet, 40 MG, 1 tablet, Orally, Once a day.  <br/>Notes: Follow low fat diet, increase physical activity, and medication compliance a must, make sure to keep routine lab updates to evaluate cholesterol.  </td></tr><tr><td/></tr><tr><td><span class="bold">7. Others </span> <br/>Notes: Walk 30 minutes 5 days each week.<br/>Verbalize an understanding of the relationship between weight loss, weight control, and exercise.  </td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedure Codes:</span> 3078F DIAST BP &lt; 80 MM HG3074F SYST BP LT 130 MM HG1158F ADVNC CARE PLAN TLK DOCD3288F FALL RISK ASSESSMENT DOCDG8417 BMI &gt;=30 CALCUATE W/FOLLOWUP1101F PT FALLS ASSESS-DOC'D LE1/YR3051F HG A1C&gt;EQUAL 7.0%&lt;8.0%3008F BODY MASS INDEX DOCD1170F FXNL STATUS ASSESSED1159F MED LIST DOCD IN RCRD1160F RVW MEDS BY RX/DR IN RCRD1157F ADVNC CARE PLAN IN RCRDG8427 DOC MEDS VERIFIED W/PT OR RE1126F AMNT PAIN NOTED NONE PRSNT</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Follow Up:</span> 3 Months (Reason: Labs 1 week before office visit)</td></tr></tbody></table></li></ul><br/><content><span class="bold">Billing  Information:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Visit Code:</span></content> <br/>99214 Office Visit, Est Pt., Level 4.  </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Procedure Codes:</span></content> <br/>3078F DIAST BP &lt; 80 MM HG. <br/>3074F SYST BP LT 130 MM HG. <br/>1158F ADVNC CARE PLAN TLK DOCD. <br/>3288F FALL RISK ASSESSMENT DOCD. <br/>G8417 BMI &gt;=30 CALCUATE W/FOLLOWUP. <br/>1101F PT FALLS ASSESS-DOC'D LE1/YR. <br/>3051F HG A1C&gt;EQUAL 7.0%&lt;8.0%. <br/>3008F BODY MASS INDEX DOCD. <br/>1170F FXNL STATUS ASSESSED. <br/>1159F MED LIST DOCD IN RCRD. <br/>1160F RVW MEDS BY RX/DR IN RCRD. <br/>1157F ADVNC CARE PLAN IN RCRD. <br/>G8427 DOC MEDS VERIFIED W/PT OR RE. <br/>1126F AMNT PAIN NOTED NONE PRSNT. </td></tr></tbody></table></li></ul><br/><tr><td valign="top"><span class="bold">Care Plan Details</span><ul><li><table cellpadding="1" cellspacing="0" border="1"><tbody/></table></li></ul></td></tr><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top"/></tr><tr><td/></tr><tr><td/></tr><tr><td valign="top">Electronically signed by [REDACTED] , APRN, APRN9397644  on [REDACTED] 11:22 AM EDT</td></tr><tr><td valign="top">Sign off status: Completed</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> [REDACTED], ARNP</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td/><td align="right"><span class="content_span">Generated for Printing/Faxing/eTransmitting on: [REDACTED] 01:30 PM EDT</span></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><br/><br/>
</body></html>